Skip to main content Skip to secondary navigation

The Vaxgen Story

Duration
5:00
Part of Series
Entrepreneurial Thought Leaders

Genentech and Vaxgen have spent a total of 20 years and $300 million on developing the vaccine, says Francis, but there is still a long way to go. Francis discusses some of the difficulties they have faced along the way.